Cargando…
Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer
BACKGROUND: The gut microbiome is important in the development and immunotherapy efficacy of lung cancer. However, the relationship between the intestinal flora and chemotherapy outcomes remains unclear and was investigated in this study. METHODS: We analyzed baseline stool samples from patients wit...
Autores principales: | Zhao, Zhe, Fei, Kailun, Bai, Hua, Wang, Zhijie, Duan, Jianchun, Wang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779204/ https://www.ncbi.nlm.nih.gov/pubmed/33111503 http://dx.doi.org/10.1111/1759-7714.13711 |
Ejemplares similares
-
Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC
por: Huang, Yiyi, et al.
Publicado: (2023) -
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non–Small Cell Lung Cancer: A Phase 1 Trial
por: Wang, Zhijie, et al.
Publicado: (2020) -
A new chapter in immune checkpoint inhibitor therapy: starting with advanced lung squamous cell carcinoma
por: Fei, Kailun, et al.
Publicado: (2020) -
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
por: Wen, Chengping, et al.
Publicado: (2017) -
Gut Microbiota and Metagenomic Advancement in Digestive Disease
por: Yu, Jinsheng, et al.
Publicado: (2016)